Oppenheimer analyst Mark Breidenbach reiterated an Outperform rating and $36.00 price target on Caribou Biosciences Inc. (NASDAQ: CRBU), following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE